Shreeram C. Nallar

发表

Oncosuppressor protein p53 and cyclin‐dependent kinase inhibitor p21 regulate interstitial cystitis associated gene expression

D. Kalvakolanu, P. Gade, S. Keay, 2018, Cytokine.

p16INK4A enhances the transcriptional and the apoptotic functions of p53 through DNA‐dependent interaction

A. Aboussekhra, D. Kalvakolanu, H. Al-Khalaf, 2017, Molecular carcinogenesis.

Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.

D. Kalvakolanu, C. Peng, W. Xiao, 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways

S. Vogel, Daniel Prantner, Shreeram C. Nallar, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Autocrine-Paracrine Prostaglandin E2 Signaling Restricts TLR4 internalization and TRIF Signaling

B. Koller, S. Vogel, Wendy Lai, 2018, Nature Immunology.

Critical Role for Transcription Factor C/EBP- (cid:2) in Regulating the Expression of Death-Associated Protein Kinase 1 (cid:1) †

D. Kalvakolanu, P. Gade, Shreeram C. Nallar, 2008 .

GRIM-19 and p16INK4a Synergistically Regulate Cell Cycle Progression and E2F1-responsive Gene Expression*

S. Reddy, D. Kalvakolanu, A. Raha, 2010, The Journal of Biological Chemistry.

Retraction: Identification and characterization of GRIM-1, a cell-death-associated gene product.

D. Kalvakolanu, D. Lindner, J. D'cunha, 2021, Journal of cell science.

Identification and characterization of GRIM-1, a cell-death-associated gene product

D. Kalvakolanu, D. Lindner, J. D'cunha, 2010, Journal of Cell Science.

The Cyclin–Dependent Kinase Inhibitor p16 Physically Interacts with the Transcription Factor Sp1 and the Cyclin– Dependent Kinase 4 to Transactivate microRNA-141 and microRNA-146b-5p Spontaneously and in Response to UV- induced DNA Damage

A. Aboussekhra, H. Al-Khalaf, P. Mohideen, 2013 .

Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance

J. Papadimitriou, D. Kalvakolanu, B. Gastman, 2012, Molecular and Cellular Biology.

GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis

S. Reddy, D. Kalvakolanu, D. Lindner, 2013, Oncogene.

A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses

S. Vogel, A. Medvedev, C. Feng, 2020, The Journal of experimental medicine.

Dissociation of TRIF bias and adjuvanticity.

S. Vogel, Wendy Lai, R. Ernst, 2020, Vaccine.

GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

D. Kalvakolanu, Shreeram C. Nallar, Shreeram C Nallar, 2017, Cytokine & growth factor reviews.

Cytokine-induced tumor suppressors: a GRIM story.

D. Kalvakolanu, S. Kalakonda, Shreeram C. Nallar, 2010, Cytokine.

Tumor-derived Mutations in the Gene Associated with Retinoid Interferon-induced Mortality (GRIM-19) Disrupt Its Anti-signal Transducer and Activator of Transcription 3 (STAT3) Activity and Promote Oncogenesis*

D. Kalvakolanu, D. Lindner, R. Lorenz, 2013, The Journal of Biological Chemistry.

Tumorigenesis and Neoplastic Progression Identification of a Structural Motif in the Tumor-Suppressive Protein GRIM-19 Required for Its Antitumor Activity

Y. Ohmori, D. Kalvakolanu, D. Lindner, 2010 .

GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring

D. Kalvakolanu, D. Lindner, Stuart S. Martin, 2008, Oncogene.

Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

S. Reddy, D. Kalvakolanu, S. Goldblum, 2007, The American journal of pathology.

Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.

S. Reddy, D. Kalvakolanu, D. Lindner, 2007, Cancer research.

Interferons, signal transduction pathways, and the central nervous system.

D. Kalvakolanu, Shreeram C. Nallar, Shreeram C Nallar, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

The Cyclin-dependent Kinase Inhibitor p16INK4a Physically Interacts with Transcription Factor Sp1 and Cyclin-dependent Kinase 4 to Transactivate MicroRNA-141 and MicroRNA-146b-5p Spontaneously and in Response to Ultraviolet Light-induced DNA Damage*

A. Aboussekhra, D. Kalvakolanu, H. Al-Khalaf, 2013, The Journal of Biological Chemistry.

Critical Role for Transcription Factor C/EBP-β in Regulating the Expression of Death-Associated Protein Kinase 1

S. Roy, D. Kalvakolanu, P. Gade, 2008, Molecular and Cellular Biology.

Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in mice

G. Fiskum, E. Rorke, R. Munivenkatappa, 2013, Proceedings of the National Academy of Sciences.

Regulation of the Death-Associated Protein Kinase 1 Expression and Autophagy via ATF6 Requires Apoptosis Signal-Regulating Kinase 1

D. Kalvakolanu, A. Cross, P. Gade, 2014, Molecular and Cellular Biology.

Regulation of snoRNAs in cancer: close encounters with interferon.

D. Kalvakolanu, Shreeram C. Nallar, Shreeram C Nallar, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

GRIM-19 Disrupts E6/E6AP Complex to Rescue p53 and Induce Apoptosis in Cervical Cancers

D. Kalvakolanu, K. Shen, Jie Sun, 2011, PloS one.

GRIM-1, a Novel Growth Suppressor, Inhibits rRNA Maturation by Suppressing Small Nucleolar RNAs

S. Reddy, D. Kalvakolanu, P. Gade, 2011, PloS one.

Interferons: Cellular and Molecular Biology of Their Actions

D. Kalvakolanu, S. Kalakonda, Shreeram C. Nallar, 2014 .

Classically activated mouse macrophages produce methylglyoxal that induces a TLR4‐ and RAGE‐independent proinflammatory response

K. D. Collins, S. Vogel, D. Spiegel, 2020, Journal of leukocyte biology.

Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges

D. Kalvakolanu, De-qi Xu, Shreeram C. Nallar, 2017, Cytokine.